For critically ill patients with advanced heart or lung failure, extracorporeal membrane oxygenation (ECMO) is available at Baylor University Medical Center and three other Baylor Scott & White Health (BSWH) medical centers. A systemwide coordinated care initiative that aligned the services at these hospitals in North and Central Texas has improved ECMO outcomes across all sites, including a 32 percent reduction in overall mortality.
Two-year outcomes data on Transcatheter Aortic Valve Replacement (TAVR) in low-risk patients were recently presented at the American College of Cardiology 2020 Annual Scientific Session. PARTNER 3 demonstrated that TAVR with the Sapien 3 valve was as safe and effective as traditional open surgical replacement for low risk patients with aortic stenosis (AS). The primary outcome of the study—the risk of death, stroke or rehospitalization at two years—was comparable between the two groups.
Cardiovascular disease is the leading cause of death in US women. However, many women present with atypical symptoms of cardiovascular disease risk. They often go untreated and are not seen again until a life-threatening cardiac event occurs. Researchers at Baylor Scott & White Medical Center – Temple, TX are participating in a clinical trial aimed at helping these women.
Clinical trials for new minimally invasive technologies have the potential for improved recovery times and reduced pain for patients with aortic arch conditions. Baylor Scott & White The Heart Hospital – Plano is the major center for clinical trials for diseases of the aorta in North Texas, and their work has put them at the forefront of minimally invasive therapies.
Researchers at Baylor Scott & White recently co-authored a paper published in CardioRenal Medicine addressing RAASi applications for acute heart failure patients.
